Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 224

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer

Open access
Bowling, Elizabeth A., Wang, Jarey H., Gong, Fade, Wu, William, Neill, Nicholas J., Kim, Ik Sun, Tyagi, Siddhartha, Orellana, Mayra, Kurley, Sarah J., Dominguez-Vidaña, Rocio, Chung, Hsiang-Ching, Hsu, Tiffany Y.-T., Dubrulle, Julien, Saltzman, Alexander B., Li, Heyuan, Meena, Jitendra K., Canlas, Gino M., Chamakuri, Srinivas, Singh, Swarnima, Simon, Lukas M., Olson, Calla M., Dobrolecki, Lacey E., Lewis, Michael T., Zhang, Bing, Golding, Ido, Rosen, Jeffrey M., Young, Damian W., Malovannaya, Anna, Stossi, Fabio, Miles, George, Ellis, Matthew J., Yu, Lihua, Buonamici, Silvia, Lin, Charles Y., Karlin, Kristen L., Zhang, Xiang H.-F., Westbrook, Thomas F.·2021·Cell

Abstract

SUMMARY Many oncogenic insults deregulate RNA splicing, often leading to hypersensitivity of tumors to spliceosome-targeted therapies (STTs). However, the mechanisms by which STTs selectively kill cancers remain largely unknown. Herein, we discover that mis-spliced RNA itself is a molecular trigger for tumor killing through viral mimicry. In MYC-driven triple-negative breast cancer, STTs cause widespread cytoplasmic accumulation of mis-spliced mRNAs, many of which form double-stranded structures. Double-stranded RNA (dsRNA)-binding proteins recognize these endogenous dsRNAs, triggering antiviral signaling and extrinsic apoptosis. In immune-competent models of breast cancer, STTs cause tumor cell-intrinsic antiviral signaling, downstream adaptive immune signaling, and tumor cell death. Furthermore, RNA mis-splicing in human breast cancers correlates with innate and adaptive immune signatures, especially in MYC-amplified tumors that are typically immune-cold. These findings indicate that dsRNA-sensing pathways respond to global aberrations of RNA splicing in cancer and provoke the hypothesis that STTs may provide unexplored strategies to activate anti-tumor immune pathways.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2020.12.031

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 224

Metadata

Authors
Bowling, E. A., Wang, J. H., Gong, F., Wu, W., Neill, N. J., Kim, I. S., Tyagi, S., Orellana, M., Kurley, S. J., Dominguez-Vidaña, R., Chung, H.-C., Hsu, T. Y.-T., Dubrulle, J., Saltzman, A. B., Li, H., Meena, J. K., Canlas, G. M., Chamakuri, S., Singh, S., Simon, L. M., Olson, C. M., Dobrolecki, L. E., Lewis, M. T., Zhang, B., Golding, I., Rosen, J. M., Young, D. W., Malovannaya, A., Stossi, F., Miles, G., Ellis, M. J., Yu, L., Buonamici, S., Lin, C. Y., Karlin, K. L., Zhang, X. H.-F., & Westbrook, T. F.
Venue
Cell
Publisher
Elsevier BV
Published
2021-01
Volume
184
Issue
2
Pages
384-403.e21
ISSN
0092-8674 (ISSN-L)
OpenAlex
W3119554079
Cited by
224
References
32
FWCI
10.73
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.